JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraus, R. L.
Right arrow Articles by Striessnig, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraus, R. L.
Right arrow Articles by Striessnig, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 13, 9239-9243, March 31, 2000


Three New Familial Hemiplegic Migraine Mutants Affect P/Q-type Ca2+ Channel Kinetics*

Richard L. Kraus, Martina J. SinneggerDagger , Alexandra Koschak, Hartmut Glossmann, Stefania Stenirri§, Paola Carrera§, and Jörg Striessnig

From the Institut für Biochemische Pharmakologie, Peter-Mayr-Strasse 1, Innsbruck A-6020, Austria, and the § Clinical Molecular Biology Laboratory, Hospitale San Raffaele, Milan 20132, Italy

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Missense mutations in the pore-forming human alpha 1A subunit of neuronal P/Q-type Ca2+ channels are associated with familial hemiplegic migraine. We studied the functional consequences on P/Q-type Ca2+ channel function of three recently identified mutations, R583Q, D715E, and V1457L after introduction into rabbit alpha 1A and expression in Xenopus laevis oocytes. The potential for half-maximal channel activation of Ba2+ inward currents was shifted by > 9 mV to more negative potentials in all three mutants. The potential for half-maximal channel inactivation was shifted by > 7 mV in the same direction in R583Q and D715E. Biexponential current inactivation during 3-s test pulses was significantly faster in D715E and slower in V1457L than in wild type. Mutations R583Q and V1457L delayed the time course of recovery from channel inactivation. The decrease of peak current through R583Q (30.2%) and D715E (30.1%) but not V1457L (18.7%) was more pronounced during 1-Hz trains of 15 100-ms pulses than in wild type (18.2%). Our data demonstrate that the mutations R583Q, D715E, and V1457L, like the previously reported mutations T666M, V714A, and I1819L, affect P/Q-type Ca2+ channel gating. We therefore propose that altered channel gating represents a common pathophysiological mechanism in familial hemiplegic migraine.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Voltage-gated P/Q-type Ca2+ channels are expressed on cell bodies and dendrites of cerebellar Purkinje cells and other neurons (1-3) where they are thought to control neuronal excitability, gene expression, neuronal plasticity, and differentiation. These channels are also expressed on presynaptic terminals (3) mediating depolarization-induced Ca2+ influx tightly coupled to neurotransmitter release (4). The Ca2+-selective pore of P/Q-type Ca2+ channels is formed by alpha 1A subunits, which also contain the voltage sensors. alpha 1A is encoded by the human gene CACNA1A on chromosome 19p13 (5).

P/Q-type Ca2+ channels have received much attention recently because CACNA1A mutations have been described which are responsible for at least three different neurological human diseases: episodic ataxia type 2 (EA-2),1 spinocerebellar ataxia type 6, and familial hemiplegic migraine (FHM) with and without cerebellar ataxia. These mutations may provide important insight into how altered Ca2+ signaling and neuronal excitability can lead to neurodegeneration and episodic neurological diseases such as migraine.

Four nonsense mutations (6-8), three splice site mutations, and four deletions in CACNA1A (5, 7) have been found to segregate in patients with EA-2. Small CAG expansions were observed in a large series of patients with spinocerebellar ataxia type 6 (9), and a further CACNA1A missense mutation was identified in a patient with severe progressive ataxia (10). At least seven missense mutations have been identified in families with FHM (5, 11-13). Defects in the alpha 1A gene are also responsible for the phenotypes (absence epilepsy and ataxia) of tottering (tg) and leaner (tgla) mutant mice (14) and may also occur in more common forms of migraine (15).

The mechanisms by which these mutations cause these abnormal phenotypes is unclear. Mutations causing EA-2, an autosomal dominant disease, are predicted to give rise to truncated, presumably nonfunctional alpha 1A proteins.2 This must result in a partial loss of P/Q-type Ca2+ channel function.

In contrast, we (16) and others (17) have shown recently that alpha 1A missense mutations causing FHM do not prevent channel activity. FHM is a rare autosomal dominant form of migraine with aura, associated with ictal hemiparesis and, in some families, with cerebellar ataxia and atrophy (18). Functional expression of rabbit alpha 1A subunits containing the FHM mutations T666M, V714A, and I1811L revealed mutation-induced changes in gating kinetics altering the extent to which P/Q-type channels accumulate in inactivation during trains of depolarizing pulses. We therefore proposed that this could alter Ca2+ influx and signaling during episodes of high neuronal activity. This in turn might result in a long term activation of neurons within the proposed "migraine generator" in the brainstem discovered by brain imaging in migraine patients (19).

Essentially the same changes in gating kinetics were reported by Hans et al. (17) after introduction of the same FHM mutations in human alpha 1A followed by heterologous expression in human embryonic kidney 293 cells and patch clamp analysis. In addition, they reported mutation-induced changes in single channel kinetics and expression density.

In the current study we examined the functional effects of three recently published FHM mutations, R583Q, D715E, and V1457L (11-13) to address further the important questions of whether all FHM mutations yield functional Ca2+ channels and if altered channel gating represents a key pathophysiological principle in FHM as proposed from initial studies.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutant alpha 1A cDNAs-- Mutations were introduced into rabbit class A Ca2+ channel alpha 1A cDNA (BI-II, 1) by applying the "gene-SOEing" technique (20) as described previously (21). Nucleotide positions of endonuclease restriction sites are given in parentheses. alpha 1A mutants were cloned into the polyadenylating transcription plasmids pSPCBI-2 (1) or pNKS2 (a gift of O. Pongs).

Single mutants R583Q and D715E were constructed according to the previously described procedure for generation of single mutants T666M and V714A (16).

Mutation V1457L (corresponding to V1465L in rabbit alpha 1A, see legend to Fig. 1) as well as a silent mutation (codon for rabbit Asp-1545 GAC to GAT) were introduced simultaneously into rabbit class A cDNA by polymerase chain reaction to yield a ClaI restriction sequence. The mutated polymerase chain reaction fragment was cut SfiI (4290)-ClaI* (4925) and coligated with a NheI (3543)-SfiI (4290) fragment of BI-II into AL20 NheI (3543)-ClaI (homologous position to ClaI*) (22) to yield complete rabbit alpha 1A cDNA sequence.

All polymerase chain reaction-generated fragments were sequenced completely to confirm sequence integrity.

Expression of alpha 1A Mutants in Xenopus laevis Oocytes-- Preparation of stage V-VI oocytes from X. laevis and injection of cRNA are described in detail elsewhere (21). Capped run-off poly(A)+ cRNA transcripts from XbaI-linearized cDNA templates were synthesized according to the procedures of Krieg and Melton (23). alpha 1 cRNAs were coinjected with beta 1a (24) and alpha 2-delta (25) subunit cRNAs. To exclude effects of endogenous Ca2+-activated Cl- currents on current kinetics, experiments were carried out in oocytes previously injected with 50-100 nl of a 0.1 M BAPTA solution.

Electrophysiological Recordings-- Inward Ba2+ currents (IBa) through expressed channel complexes were measured using the two-microelectrode voltage clamp technique as described previously (21). Similar current amplitudes were obtained with mutant and wild-type alpha 1A subunits. Oocytes expressing peak IBa smaller than 400 nA or larger than 1.8 µA were excluded from analysis. Data analysis and acquisition were performed by using the pClamp software package (version 6.0, Axon Instruments).

Recordings were carried out at room temperature in a bath solution containing 40 mM Ba(OH)2, 50 mM NaOH, 2 mM CsOH, 5 mM HEPES, adjusted to a pH of 7.4 with methanesulfonic acid. Voltage recording and current injecting microelectrodes were filled with 2.8 M CsCl, 0.2 M CsOH, 10 mM EGTA, 10 mM HEPES (adjusted to pH 7.4 with HCl) and had resistances of 0.3-2 megohm.

Recovery of IBa from inactivation was studied using a double-pulse protocol. After a 3-s depolarizing prepulse to +10 mV (holding potential -80 mV) the time course of IBa recovery was determined at -60 mV by applying 300-ms test pulses to +10 mV at various time intervals after the prepulse. Peak IBa was normalized to the peak current amplitude measured during the prepulse. IBa was then allowed to recover for 1 min at -100 mV. This double-pulse protocol was repeated individually for each recovery time interval in the same oocyte.

The voltage dependence of inactivation (steady-state inactivation) was determined from normalized inward currents elicited during steps to +10 mV after 10-s steps to various holding potentials. The voltage dependence of activation was determined from I-V curves obtained by step depolarizations from a holding potential of -80 mV to various test potentials. The half-maximal voltage for activation (V0.5,act), the slope factor of the curve at V0.5,act (kact,), the half-maximal voltage for steady-state inactivation (V0.5,inact), and the slope factor of the curve (kinact) were obtained by fitting the data to the Boltzmann equation. Apparent reversal potentials were calculated by extrapolation from I-V relationships.

Data Analysis-- Nonlinear least square fitting and statistical calculations were performed using OriginR 5.0 (Microcal). Data are given as means ± S.E. for the indicated number of experiments.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutations R583Q, D715E, and V1457L, illustrated in Fig. 1A, are located in highly conserved and functionally important regions of the human alpha 1A subunit of neuronal P/Q-type Ca2+ channels. Mutation R583Q neutralizes a positive charge in transmembrane segment S4 of the channel in domain II (IIS4). S4 segments form part of the voltage sensor of voltage-gated Ca2+ channels (26). D715E is located in IIS6 adjacent to mutation V714A analyzed in our previous study and V1457L in the S5-S6 linker of domain III. Segments S5 and S6 and their connecting linkers are assumed to form the pore of the channel (26). We introduced the single mutations into the corresponding positions of the highly homologous rabbit alpha 1A subunit (wild type, Ref. 1) and analyzed mutant channels for changes in their biophysical properties after functional expression in X. laevis oocytes (together with accessory beta 1 and alpha 2-delta subunits) using the two-microelectrode voltage clamp technique.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   FHM mutations alter Ca2+ current kinetics. Panel A, proposed folding structure of Ca2+ channel alpha 1 subunits. The approximate positions of the new identified FHM mutations are indicated by black circles, previously reported FHM mutations (16) by open circles. Human mutation V1457L corresponds to V1465L in rabbit alpha 1A. Panel B, IBa elicited by 3-s depolarizations from a holding potential of -80 mV to a test potential of +10 mV. Traces were normalized to the peak current amplitude. Normalized representative current traces are shown (cells: wild type (WT), R7813001; R583Q, R0804046; D715E, R0508006; V1457L, R3103030). Traces were fitted to a biexponential decay yielding the following time constants for the fast (tau fast) and slow (tau slow) component: wild type: 0.222, 0.897 s; R583Q: 0.205, 0.779 s; D715E: 0.141, 0.564 s; V1457L: 0.252, 1.255 s. Panel C, effect of mutations on tau fast and tau slow. tau  was calculated as in panel B. Data are the means ± S.E. for n = 5-20. Statistical significance (p < 0.01) is indicated by asterisks. tau fast: wild type, 0.228 ± 0.014 s; R583Q, 0.197 ± 0.008 s; D715E, 0.142 ± 0.004 s; V1457L, 0.252 ± 0.007 s. tau slow: wild type, 0.806 ± 0.077 s; R583Q, 0.789 ± 0.017 s; D715E, 0.578 ± 0.008 s; V1457L, 1.229 ± 0.034 s.

The potential for half-maximal activation (V0.5,act) was significantly (p < 0.01) shifted to hyperpolarized potentials for all three mutants without changing the steepness of the steady-state activation curve (Table I). This effect was most pronounced in D715E. The midpoint voltage for steady-state inactivation was not altered in mutant V1457L, but a significant shift to more negative potentials occurred in R583Q and D715E (Table I). Apparent reversal potentials were similar for all constructs (53-59 mV) ruling out major changes in Ba2+ permeability.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effects of mutations on activation and inactivation properties
The half-maximal voltage for activation (V0.5,act), the steepness of the curve at V0.5,act (kact), the half-maximal voltage for steady-state inactivation (V0.5,inact), and the steepness of the curve at V0.5,inact (kinact) were obtained by fitting the data to the Boltzmann equation. Data are means ± S.E. for n = 9-26. Asterisks indicate a statistically significant (p < 0.01) difference from wild type. zg, apparent gating charge obtained by dividing 25.26 (=RT/F at 20 °C)/kact. WT, wild type.

To investigate whether the FHM mutations affect the time course of channel inactivation we analyzed the current decay during 3-s test pulses elicited from a holding potential of -80 mV to +10 mV (Fig. 1B). For wild-type and mutant channels the time course of inactivation could be well described by a double-exponential function. D715E significantly (p < 0.01) accelerated both the time constant for the initial fast component (tau fast = 0.142 ± 0.004 s, n = 15) and the slow component (tau slow = 0.577 ± 0.008 s, n = 15) of current decay compared with wild type (tau fast = 0.227 ± 0.013 s; tau slow = 0.806 ± 0.076 s, n = 5) (Fig. 1C). Mutation V1457L increased the time constant for the slow component of the current decay (tau slow = 1.2 ± 0.033 s, n = 11). In R583Q tau fast was also slightly accelerated, but this did not reach the level of statistical significance. The contribution of the fast component (wild type: 43.8 ± 2.0%, n = 5) was increased significantly in D715E (57.8 ± 1.5%, n = 14; p < 0.01) and decreased in V1457L (27.4 ± 2.3%, n = 10, p < 0.01).

Next we tested whether the mutations also change the extent of peak IBa decrease during pulse trains which reflects accumulation of channels in inactivation. Application of 15 100-ms pulses from a holding potential of -60 mV to a test potential of +10 mV at a frequency of 1 Hz caused a significant (p < 0.01) increase of accumulation in inactivation for mutants R583Q and D715E but not V1457L. Current decay after 15 pulses was 1.6-fold larger in R583Q (30.2 ± 0.8%; n = 35) and D715E (30.1 ± 1.5%; n = 18) than in wild type (19.1 ± 1%; n = 19) (Fig. 2, A and B).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Mutations affect IBa decay during 1-Hz pulse trains. Panel A, 1-Hz trains of 15 100-ms pulses were applied from a holding potential of -60 mV to a test potential of +10 mV. Peak currents during each pulse were normalized to the peak IBa during the first pulse (control) and are plotted against pulse number. Peak IBa decay after 15 pulses (given in percent of the control current) was as follows: wild type (WT), 19 ± 1; R583Q, 30 ± 0.8; D715E, 30 ± 1.4; V1457A, 19 ± 0.7 (means ± S.E., n = 18-35). Panel B, representative current traces are shown for wild type (cell R7731c74), R583Q (cell R3103043), D715E (cell R0508013), and V1457L (cell R3103023).

The fraction of channels inactivating during frequent depolarizations not only depends on the inactivation rate during the pulses but also on the rate of recovery from inactivation between pulses. Therefore recovery from inactivation was measured employing a double-pulse protocol (Fig. 3A). Channels were inactivated by a 3-s conditioning prepulse from -80 to +10 mV. The time course of recovery was then determined at -60 mV by applying 300-ms test pulses to +10 mV after various time intervals after the prepulse (Fig. 3A). Between single double-pulse experiments the oocytes were held at -100 mV for 60 s to allow full recovery of IBa. Recovery was determined at -60 mV to maximize the difference between wild-type and mutant channels. In wild-type and mutant channels about 90% of IBa recovered after 20 s. In all constructs recovery of IBa followed a biexponential time course (Fig. 3B). In both R583Q and V1457L the fraction of recovered current at all time intervals measured was significantly smaller (p < 0.01) than in wild type. No change was observed for D715E (Fig. 3B).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   Mutations affect IBa recovery from inactivation. Panel A, recovery from inactivation was measured using a double-pulse protocol. After a 3-s depolarizing prepulse to +10 mV (holding potential -80 mV) the time course of IBa was determined at -60 mV by applying 300-ms test pulses to +10 mV at various time intervals after the prepulse. A representative trace of a recovery experiment for R583Q (cell R1205027) is illustrated. Panel B, fractional IBa recovery from inactivation after various periods of time (0.05, 0.1, 0.2, 0.5, 1, 2, 3, 5, 10, 15, 20 s). Note that fractional recoveries of R583Q and V715L were statistically different from wild type (WT) (p < 0.01) at all time points tested. The inset shows fractional current recovery after selected time points (0.5, 3, and 15 s) for clarity. Statistical significance (p < 0.01) is indicated by asterisks. Means ± S.E. are given for n = 5-20.

In summary, our experiments convincingly show that all newly discovered alpha 1A mutations in patients with FHM cause abnormal gating behavior of P/Q-type Ca2+ channels. Gating changes therefore seem to represent an elementary mechanism underlying P/Q-type Ca2+ channel dysfunction in FHM.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have studied the functional consequences of three recently identified FHM missense mutations, R583Q, D715E, and V1457L within the alpha 1A subunit of neuronal P/Q-type Ca2+ channels. None of the mutations resulted in a nonfunctional channel as proposed for EA-2 mutations in the alpha 1A subunit gene. EA-2 mutations (5, 7) are believed to be incompatible with the expression of a functional protein. In the presence of an unaffected gene, it is therefore likely that the observed neurological phenotype in EA-2 results from a reduced activity of P/Q-type Ca2+ channels in the central nervous system. Instead, two independent mechanisms can affect P/Q-type currents in FHM patients: altered expression density and changes in channel gating. Hans et al. (17) have recently found that FHM mutations decrease or increase the density of functional P/Q-type currents after heterologous expression in Xenopus oocytes or mammalian cells. It is difficult to predict if these changes of expression density also occur in vivo where, in addition to the accessory alpha 2-delta and beta  subunits, alpha 1A interacts with a number of other modulatory proteins such as G-proteins (27), calmodulin (28), and synaptic vesicle proteins (29). Clearly, this important question can only be addressed in animal models containing the respective mutations.

A second mechanism by which FHM mutations can affect P/Q-type Ca2+ currents is by changing channel gating. Our electrophysiological analysis provides convincing evidence that such changes also occur in three recently identified FHM mutations. Together with our previous results (16) this allows us to conclude that, irrespective of changes in expression density, this represents an elementary functional alteration underlying P/Q-type Ca2+ channel dysfunction in FHM.

As for T666M, V714A, and I1811L, all three new mutations significantly shifted the voltage dependence of activation to more negative potentials. In the absence of changes in the slope of the activation curve this must result in a more negative threshold of Ca2+ channel activation. This could lead to altered Ca2+ signaling by increasing P/Q-type Ca2+ channel activity at weak depolarizations. Two of the mutations also caused a more pronounced decrease of IBa during pulse trains, reflecting altered accumulation of channels in inactivation. This can result from either increased inactivation during the pulse or delayed recovery from inactivation between pulses. Our experiments demonstrate that it is due to slower recovery from inactivation in R583Q and faster inactivation in D715E. In V1457L decrease of IBa during the train was not different from wild type. This can be explained by the slower inactivation kinetics, which are counteracted by the slowed recovery from inactivation. Altered accumulation of channels in inactivation during rapid depolarizations could cause changes in Ca2+ influx especially during high but not during low neuronal activity. This may underlie the episodic character of FHM with attacks triggered by sensory or emotional stimuli.

In addition to the potential insight into the pathophysiology of migraine, mutations R583Q and D715E also provide us with interesting molecular information about channel function. As in the previously analyzed mutant R192Q (16), R583Q eliminates a conserved positive charge at the extracellular side of transmembrane S4-helix, which forms part of the voltage sensor of the channel. The charge neutralization at position 583 in IIS4 (R583Q) shifted the voltage dependence of activation (and inactivation) to more negative potentials and slowed recovery from inactivation. These findings indicate that not only mutations in the putative pore region (T666M, V714A, I1811L) but also in the S4 segments can alter alpha 1A recovery from inactivation. This illustrates that conformational changes of voltage-sensing portions of alpha 1A are involved in this process.

Mutation R583Q caused a negative shift of V0.5,act without a change in the apparent gating charge, zg (Table I). Based on a simplified model describing the gating of a channel with only two states (open and closed) (Equation 2-22 in Ref. 30; 31) a negative shift of V0.5,act suggests that this mutation decreases the conformational energy difference between the closed and open states.

By assuming a model in which the voltage sensors in all four repeats move independently it can be predicted that Arg-583 (in IIS4) forms part of a voltage sensor which moves over potentials close to those causing channel opening. This is in contrast to data reported earlier for an alpha 1S (skeletal muscle)/alpha 1C (cardiac muscle) chimera where this was observed for sensors in repeats I and III but not in repeat II. Therefore this naturally occurring mutation clearly demonstrates that voltage sensor movements vary not only between different voltage-dependent cation channels (31) but even between different Ca2+ channel alpha 1 subunits.

Mutation D715E is located adjacent to mutation V714A. Together with I1811L in IVS6 these are believed to be located close to the cytoplasmic mouth of the pore. Unlike V714A and I1811L, D715E did not affect recovery from inactivation and prominently accelerated current inactivation upon depolarization. These data indicate that the cytoplasmic end of S6 helices comprise a functionally relevant region within alpha 1A which tightly controls the channel's inactivation properties. Although our data do not allow us to propose a defined molecular mechanism for this process they clearly show that even minor structural changes such as the introduction of a single side chain methyl group in mutant D715E are sufficient to disturb this functional domain.

The present work clearly shows that mutations in the human CACNA1A gene alter the gating properties of neuronal P/Q-type Ca2+ channels in all seven FHM mutants analyzed so far. This provides a rational basis for the generation of mutant mice containing selected mutations. Introduction of FHM mutations differing with respect to their biophysical properties should enable electrophysiological analysis of the consequences of altered channel gating for neuronal Ca2+ signaling in FHM and more common forms of migraine (15).

    ACKNOWLEDGEMENTS

We thank E. Wappl and E. Emberger for help in construction of mutants and P. Dietl for critical comments on the manuscript.

    FOOTNOTES

* This work was supported in part by Fonds zur Förderung der Wissenschaftlichen Forschung Grants P-12641 (to J. S.) and P-12689 (to H. G.) and by the Österreichische Nationalbank (to J. S.), the Dr. Legerlotz Foundation, and the University of Innsbruck.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a Hertha-Firnberg fellowship.

To whom correspondence should be addressed. Tel.: 43-512-507-3164; Fax: 43-512-588-627; E-mail: joerg.striessnig@uibk.ac.at.

2 D. Kullmann, personal communication.

    ABBREVIATIONS

The abbreviations used are: EA-2, episodic ataxia type 2; FHM, familial hemiplegic migraine; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; IBa, inward Ba2+ currents; V0.5, act, half-maximal voltage for activation; kact, slope factor of the curve at V0.5,act; V0.5, inact, half-maximal voltage for steady-state inactivation; kinact, slope factor of the curve at V0.5,act.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Mori, Y., Friedrich, T., Kim, M.-S., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi, T., Mikoshiba, K., Imoto, K., Tanabe, T., and Numa, S. (1991) Nature 350, 398-402[CrossRef][Medline] [Order article via Infotrieve]
2. Stea, A., Tomlinson, W. J., Soong, T. W., Bourinet, E., Dubel, S. J., Vincent, S. R., and Snutch, T. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10576-10580[Abstract/Free Full Text]
3. Westenbroek, R. E., Sakurai, T., Elliott, E. M., Hell, J. W., Starr, T. V., Snutch, T. P., and Catterall, W. A. (1995) J. Neurosci. 15, 6403-6418[Abstract/Free Full Text]
4. Wheeler, D. B., Tsien, R. W., and Randall, A. (1994) Science 266, 828-831[Free Full Text]
5. Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffmann, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., Haan, J., Lindhout, D., van Ommen, G. J. B., Hofker, M. H., Ferrari, M. D., and Frants, R. R. (1996) Cell 87, 543-552[CrossRef][Medline] [Order article via Infotrieve]
6. Yue, Q., Jen, J. C., Thwe, M. M., Nelson, S. F., and Baloh, R. W. (1998) Am. J. Med. Genet. 77, 298-301[CrossRef][Medline] [Order article via Infotrieve]
7. Denier, C., Ducros, A., Vahedi, K., Joutel, A., Thierry, P., Ritz, A., Castelnovo, G., Deonna, T., Gerard, P., Devoize, J. L., Gayou, A., Perrouty, B., Soisson, T., Autret, A., Warter, J. M., Vighetto, A., Van Bogaert, P., Alamovitch, S., Roullet, E., and Tournier-Lasserve, E. (1999) Neurology 52, 1816-1821[Abstract/Free Full Text]
8. Jen, J., Yue, Q., Nelson, S. F., Yu, H., Litt, M., Nutt, J., and Baloh, R. W. (1999) Neurology 53, 34-37[Abstract/Free Full Text]
9. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., Amos, C., Dobyns, W. B., Subramony, S. H., Zoghbi, H. Y., and Lee, C. C. (1997) Nat. Genet. 15, 62-69[CrossRef][Medline] [Order article via Infotrieve]
10. Yue, Q., Jen, J. C., Nelson, S. F., and Bahloh, R. W. (1997) Am. J. Hum. Genet. 61, 1078-1087[CrossRef][Medline] [Order article via Infotrieve]
11. Ducros, A., Denier, C., Joutel, A., Vahedi, K., Michel, A., Darcel, F., Madigand, M., Guerouaou, D., Tison, F., Julien, J., Hirsch, E., Chedru, F., Bisgard, C., Lucotte, G., Despres, P., Billard, C., Barthez, M. A., Ponsot, G., Bousser, M. G., and Tournier-Lasserve, E. (1999) Am. J. Hum. Genet. 64, 89-98[CrossRef][Medline] [Order article via Infotrieve]
12. Battistini, S., Stenirri, S., Piatti, M., Gelfi, C., Righetti, P. G., Rocchi, R., Giannini, F., Battistini, N., Guazzi, G. C., Ferrari, M., and Carrera, P. (1999) Neurology 53, 38-43[Abstract/Free Full Text]
13. Carrera, P., Piatti, M., Stenirri, S., Grimaldi, L. M. E., Marchioni, E., Curcio, M., Righetti, P. G., Ferrari, M., and Gelfi, C. (1999) Neurology 53, 26-32[Abstract/Free Full Text]
14. Fletcher, C. F., Lutz, C. M., O'Sullivan, T. N., Shaughnessy, J. D., Hawkes, R., Frankel, W. N., Copeland, N. G., and Jenkins, N. A. (1996) Cell 87, 607-617[CrossRef][Medline] [Order article via Infotrieve]
15. May, A., Ophoff, R. A., Terwindt, G. M., Urban, C., van Eijk, R., Haan, J., Diener, H. C., Lindhout, D., Frants, R. R., Sandkuijl, L. A., and Ferrari, M. D. (1995) Hum. Genet. 96, 604-608[Medline] [Order article via Infotrieve]
16. Kraus, R. L., Sinnegger, M. J., Glossmann, H., Hering, S., and Striessnig, J. (1998) J. Biol. Chem. 273, 5586-5590[Abstract/Free Full Text]
17. Hans, M., Luvisetto, S., Williams, M. E., Spagnolo, M., Urrutia, A., Tottene, A., Brust, P. L., Johnson, E. C., Harpold, M. M., Stauderman, K. A., and Pietrobon, D. (1999) J. Neurosci. 19, 1610-1619[Abstract/Free Full Text]
18. Terwindt, G. M., Ophoff, R. A., Haan, J., Vergouwe, M. N., van Eijk, R., Frants, R. R., and Ferrari, M. D. (1998) Neurology 50, 1105-1110[Abstract/Free Full Text]
19. Diener, H. C., and May, A. (1996) Curr. Opin. Neurol. 9, 199-201[Medline] [Order article via Infotrieve]
20. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 61-68[CrossRef][Medline] [Order article via Infotrieve]
21. Grabner, M., Wang, Z., Hering, S., Striessnig, J., and Glossmann, H. (1996) Neuron 16, 207-218[CrossRef][Medline] [Order article via Infotrieve]
22. Hering, S., Aczel, S., Grabner, M., Döring, F., Berjukow, S., Mitterdorfer, J., Sinnegger, M. J., Striessnig, J., Degtiar, V. E., Wang, Z., and Glossmann, H. (1996) J. Biol. Chem. 271, 24471-24475[Abstract/Free Full Text]
23. Krieg, P. A., and Melton, D. A. (1984) Nucleic Acids Res. 12, 7057-7070[Abstract/Free Full Text]
24. Ruth, P., Roehrkasten, A., Biel, M., Bosse, E., Regulla, S., Meyer, H. E., Flockerzi, V., and Hofmann, F. (1989) Science 245, 1115-1118[Abstract/Free Full Text]
25. Ellis, S. B., Williams, M. E., Ways, N. R., Brenner, R., Sharp, A. H., Leung, A. T., Campbell, K. P., McKenna, E., Koch, W. J., Hui, A., Schwartz, A., and Harpold, M. M. (1988) Science 241, 1661-1664[Abstract/Free Full Text]
26. Armstrong, C., and Hille, B. (1998) Neuron 20, 371-380[CrossRef][Medline] [Order article via Infotrieve]
27. Herlitze, S., Garcia, D. E., Mackie, K., Hille, B., Scheuer, T., and Catterall, W. A. (1996) Nature 380, 258-262[CrossRef][Medline] [Order article via Infotrieve]
28. Lee, A., Wong, S. T., Gallagher, D., Li, B., Storm, D. R., Scheuer, T., and Catterall, W. A. (1999) Nature 399, 155-159[CrossRef][Medline] [Order article via Infotrieve]
29. Rettig, J., Sheng, Z.-H., Kim, D. K., Hodson, C. D., Snutch, T. P., and Catterall, W. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 7363-7368[Abstract/Free Full Text]
30. Hille, B. (1992) Neuron 9, 187-195[Medline] [Order article via Infotrieve]
31. Garcia, J., Nakai, J., Imoto, K., and Beam, K. G. (1997) Biophys. J. 72, 2515-2523[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
H. Khosravani and G. W. Zamponi
Voltage-gated calcium channels and idiopathic generalized epilepsies.
Physiol Rev, July 1, 2006; 86(3): 941 - 966.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
D. Pietrobon
Migraine: New Molecular Mechanisms
Neuroscientist, August 1, 2005; 11(4): 373 - 386.
[Abstract] [PDF]


Home page
NeurologyHome page
J. Wan, R. Khanna, M. Sandusky, D. M. Papazian, J. C. Jen, and R. W. Baloh
CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics
Neurology, June 28, 2005; 64(12): 2090 - 2097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. F. Barrett, Y.-Q. Cao, and R. W. Tsien
Gating Deficiency in a Familial Hemiplegic Migraine Type 1 Mutant P/Q-type Calcium Channel
J. Biol. Chem., June 24, 2005; 280(25): 24064 - 24071.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Hemara-Wahanui, S. Berjukow, C. I. Hope, P. K. Dearden, S.-B. Wu, J. Wilson-Wheeler, D. M. Sharp, P. Lundon-Treweek, G. M. Clover, J.-C. Hoda, et al.
A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation
PNAS, May 24, 2005; 102(21): 7553 - 7558.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Tottene, F. Pivotto, T. Fellin, T. Cesetti, A. M. J. M. van den Maagdenberg, and D. Pietrobon
Specific Kinetic Alterations of Human CaV2.1 Calcium Channels Produced by Mutation S218L Causing Familial Hemiplegic Migraine and Delayed Cerebral Edema and Coma after Minor Head Trauma
J. Biol. Chem., May 6, 2005; 280(18): 17678 - 17686.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-Q. Cao and R. W. Tsien
Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission
PNAS, February 15, 2005; 102(7): 2590 - 2595.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Mullner, L. A. M. Broos, A. M. J. M. van den Maagdenberg, and J. Striessnig
Familial Hemiplegic Migraine Type 1 Mutations K1336E, W1684R, and V1696I Alter Cav2.1 Ca2+ Channel Gating: EVIDENCE FOR {beta}-SUBUNIT ISOFORM-SPECIFIC EFFECTS
J. Biol. Chem., December 10, 2004; 279(50): 51844 - 51850.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. E. McRory, J. Hamid, C. J. Doering, E. Garcia, R. Parker, K. Hamming, L. Chen, M. Hildebrand, A. M. Beedle, L. Feldcamp, et al.
The CACNA1F Gene Encodes an L-Type Calcium Channel with Unique Biophysical Properties and Tissue Distribution
J. Neurosci., February 18, 2004; 24(7): 1707 - 1718.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. C. Stotz, S. E. Jarvis, and G. W. Zamponi
Functional roles of cytoplasmic loops and pore lining transmembrane helices in the voltage-dependent inactivation of HVA calcium channels
J. Physiol., January 15, 2004; 554(2): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
I. Alonso, J. Barros, A. Tuna, J. Coelho, J. Sequeiros, I. Silveira, and P. Coutinho
Phenotypes of Spinocerebellar Ataxia Type 6 and Familial Hemiplegic Migraine Caused by a Unique CACNA1A Missense Mutation in Patients From a Large Family
Arch Neurol, April 1, 2003; 60(4): 610 - 614.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Tottene, T. Fellin, S. Pagnutti, S. Luvisetto, J. Striessnig, C. Fletcher, and D. Pietrobon
Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons
PNAS, October 1, 2002; 99(20): 13284 - 13289.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. M. Kullmann
The neuronal channelopathies
Brain, June 1, 2002; 125(6): 1177 - 1195.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Wappl, A. Koschak, M. Poteser, M. J. Sinnegger, D. Walter, A. Eberhart, K. Groschner, H. Glossmann, R. L. Kraus, M. Grabner, et al.
Functional Consequences of P/Q-type Ca2+ Channel Cav2.1 Missense Mutations Associated with Episodic Ataxia Type 2 and Progressive Ataxia
J. Biol. Chem., February 22, 2002; 277(9): 6960 - 6966.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Jen, J. Wan, M. Graves, H. Yu, A. F. Mock, C. J. Coulin, G. Kim, Q. Yue, D. M. Papazian, and R. W. Baloh
Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission
Neurology, November 27, 2001; 57(10): 1843 - 1848.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Ducros, C. Denier, A. Joutel, M. Cecillon, C. Lescoat, K. Vahedi, F. Darcel, E. Vicaut, M.-G. Bousser, and E. Tournier-Lasserve
The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium Channel
N. Engl. J. Med., July 5, 2001; 345(1): 17 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Wappl, J. Mitterdorfer, H. Glossmann, and J. Striessnig
Mechanism of Dihydropyridine Interaction with Critical Binding Residues of L-type Ca2+ Channel alpha 1 Subunits
J. Biol. Chem., April 13, 2001; 276(16): 12730 - 12735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Berjukow, R. Marksteiner, S. Sokolov, R. G. Weiss, E. Margreiter, and S. Hering
Amino Acids in Segment IVS6 and beta -Subunit Interaction Support Distinct Conformational Changes during Cav2.1 Inactivation
J. Biol. Chem., May 11, 2001; 276(20): 17076 - 17082.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Stotz and G. W. Zamponi
Identification of Inactivation Determinants in the Domain IIS6 Region of High Voltage-activated Calcium Channels
J. Biol. Chem., August 24, 2001; 276(35): 33001 - 33010.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)